Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors (Q50895162)

24 March 2018

title

Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors (English)

1 reference

24 March 2018

1 reference

6

David T Curiel

1 reference

24 March 2018

Joshua J Short

1

1 reference

24 March 2018

Alexander V Pereboev

2

1 reference

24 March 2018

Yosuke Kawakami

3

1 reference

24 March 2018

Chenthamarakshan Vasu

4

1 reference

24 March 2018

Mark J Holterman

5

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 May 2004

1 reference

24 March 2018

published in

Virology

1 reference

24 March 2018

volume

322

1 reference

24 March 2018

issue

2

1 reference

24 March 2018

page(s)

349-359

1 reference

24 March 2018

Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

B70 antigen is a second ligand for CTLA-4 and CD28

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: implications for adoptive immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Enhanced neuroblastoma transduction for an improved antitumor vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

CD46 is a cellular receptor for group B adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Expression of costimulatory molecules, B7-1 and B7-2 on human gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Expression of renin-angiotensin system genes in immature and mature dendritic cells identified using human cDNA microarray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Advances in gene transfer into haematopoietic stem cells by adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Primary human mesothelioma cells express class II MHC, ICAM-1 and B7-2 and can present recall antigens to autologous blood lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Update on adenovirus and its vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Adenovirus type 11 uses CD46 as a cellular receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Expression of the adenovirus receptor and its interaction with the fiber knob

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

DC-SIGN: escape mechanism for pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Expression and function of CD28 on Epstein-Barr virus-positive B cell lines and AIDS-associated non-Hodgkin's lymphoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

Human adenovirus serotype 3 (Ad3) and the Ad3 fiber protein bind to a 130-kDa membrane protein on HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

7 January 2021

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

7 January 2021

Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

7 January 2021

Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.016

7 January 2021

10.1016/J.VIROL.2004.02.016

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018